$5.70
0.336.15%
Last update: Oct 13, 9:26 AM
$5.70
0.336.15%
STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. (SPHRY) Stock Price, Quote, News & History
SPHRYOTCQX
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. (OTCQX:SPHRY) through any online brokerage.
There are no as such competitors for STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd..
There is no analysis for STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. to provide a consensus price target.
The stock price for STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. (OTCQX: SPHRY) is $5.7 last updated October 13, 2026 at 9:26 AM EDT.
There are no upcoming dividends for STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd..
STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. does not have any upcoming earnings scheduled.
There is no upcoming split for STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd..
STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQX.
Starpharma Holdings Ltd is an Australian biotechnology company focused on developing targeted oncology therapeutics, including radiopharmaceuticals, using its clinically validated DEP (Dendrimer Enhanced Product) drug delivery platform. Leveraging...
